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Abstract
Background: E-NTPase/E-NTPDase is activated by millimolar concentrations of Ca2+ or Mg2+
with a pH optimum of 7.5 for the hydrolysis of extracellular NTP and NDP. It has been generally
accepted that E-NTPase/E-NTPDase plays regulatory role in purinergic signalling, but other
functions may yet be discovered.
Results: In this article it is proposed on the basis of published data that E-NTPase/E-NTPDase
could play a role in the influx and efflux of Ca2+and Mg2+ in vivo.
Conclusions: Attenuation of extracellular Ca2+ influx by rat cardiac sarcoplasmic anti-E-NTPase
antibodies and oligomerization studies on mammalian CD39 conclusively point towards the
existence of a new channel in the membrane. Further studies on these properties of the E-NTPase/
E-NTPDase may provide detailed mechanisms and identify the potential patho-physiological
significance.
Background
The mechanism by which [Ca2+]i is increased in excitable
cells differs from that obtaining in non-excitable cells.
Excitable cells exhibit an action potential, a substantial
general depolarization of the plasma membrane, in
response to depolarizing stimuli; influx of Ca2+ occurs via
plasma membrane Ca2+ channels and/or release from
sarco (endo) plasmic reticulum via ryanodine-receptor
Ca2+ channels which regulate the excitation – contraction
coupling [1,2]. The factors that determine the extent of
Ca2+ entry are (i) magnitude of the membrane potential
and (ii) magnitude of the transmembrane Ca2+ gradient.
These two factors also determine whether Ca2+ or Mg2+
enters and the time (probably milliseconds) that elapses
between channel opening and termination of Ca2+ or
Mg2+ transport [3].
In non-excitable cells, the increase in [Ca2+]i results from
influx of Ca2+ across the plasma membrane and Ca2+
release from the endoplasmic reticulum. Ca2+ release from
the SER depends on the binding of inositol 1,4,5-triphos-
phate (InsP3) to its receptor Ca2+channels, and also on
Ca2+ binding to ryanodine receptor – Ca2+channels.
Ca2+ is removed from the cell by the following means. i:
the sarco (endo) plasmic reticular Ca2+ pump ATPase
(SERCA), which transports Ca2+ from the cytoplasm into
the SER lumen (~70% of the activator Ca2+);  ii:  The
plasma membrane Ca2+ pump ATPase (PMCA), which
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exports Ca2+ across the plasma membrane (~1% of the
activator Ca2+); iii: Mitochondrial Ca2+Uniporters (mCa2+
uniporters), which transport Ca2+  into mitochondria
(~1% of the activator Ca2+);iv: the Na+/Ca2+ exchanger
(28% of the activator Ca2+). This last transport system is
reversible but under normal physiological conditions, in
the Ca2+ extrusion mode, it exhibits a stoichiometry of 3
Na+influx/1 Ca2+ efflux [4].
Ca2+ enters animal cells via (i) voltage-operated Ca2+chan-
nels (VOCC), (ii) ligand gated non-specific cation chan-
nels (LGCCS), and (iii) stretch/receptor activated non-
specific Ca2+ channels (RACC) [4,5]. A "receptor operated
Ca2+ channel" (ROCC) is defined as a plasma membrane
Ca2+ channel other than VOCC or RACC. VOCC opening
depends on membrane depolarization, whereas RACC
opening depends on both direct and indirect activation of
membrane bound receptors. In contrast, ROCC opening
depends solely on agonist-receptor interaction. It has also
been suggested that mobile intracellular messengers such
as elevated [Ca2+]i play a role in ROCC opening [5,6].
Different types of ROCC are activated (opened) by diverse
cell signaling mechanisms such as ligand specificity,
increase in [Ca2+]I, increase in [cAMP]i [7] and activation/
inactivation of specific trimeric G proteins [8].
Opening of Ca2+ channels must be a highly regulated
event involving physical movement of channel compo-
nents inclusive of the alteration in channel protein con-
formation; Also, an extracellular source of free energy
(∆G) could be of critical importance. This might be sup-
plied by E-NTPase/E-NTPDase mediated hydrolysis of
NTP/NDP. Co-ordination of this process might play a role
in the opening of Ca2+ channels, independently of mem-
brane depolarization or other factors.
The biochemical, structural, and functional properties of
E-type nucleotidases have been covered in several excel-
lent reviews: i. Extracellular metabolism [9]; ii. purine sig-
nalling [10,11]; iii. adhesion [12]; iv. transporter
functions [13]; v. pathophysiology [14,15].
Rationale for the proposed hypothesis: E-NTPase/E-
NTPDase mediated Ca2+/Mg2+ transport
It has been suggested that Ca2+ entry during the slow
inward current in normal myocardium involves mem-
brane-bound channels potentially controlled and/or reg-
ulated by metabolic energy transfer from unknown
sources, though Ca2+ enters the cell down its concentra-
tion gradient [16]. Electrical stimulation and membrane
phosphorylation by cAMP-dependent protein kinase have
been shown to increase E-NTPase/E-NTPDase activity.
Metal ions such as Mn2+, Co2+, Ni2+ and La2+ that attenu-
ate Ca2+ influx also inhibit the E-NTPase. In the late stages
of heart failure the E-NTPase is down regulated. Activation
of E-NTPase by various concentrations of Ca2+ has been
shown to correlate linearly with cardiac contractile force
development [17].
"Calcium paradox" is defined as irreversible functional
and structural protein loss in the isolated heart that is first
perfused with Ca2+-free buffer and then reperfused with
Ca2+-containing buffer [18]. E-NTPase activity is highest
during the initial phases of reperfusion, which might
favour the initial Ca2+ influx that causes Ca 2+ overload.
During the later stages of reperfusion with Ca2+-contain-
ing buffer there is a loss of E-NTPase activity. During mild
stages of Ca2+ paradox, E-NTPase retains its function and
continues to favour Ca2+ influx, resulting in the develop-
ment of intracellular Ca2+ overloads. However, during
severe stages of calcium paradox, impaired E-NTPase
activity may contribute to irreversible failure of contractile
force recovery [19].
To date there is no report describing the detailed mecha-
nism of E-NTPase/E-NTPDase-mediated channel gating
and its role in Ca2+/Mg2+ transport. In this article an
attempt is made to delineate the molecular mechanism of
Ca2+/Mg2+ transport, identifying the source of energy and
the activation and termination of the process. The central
issues are:
a. How the metabolic energy from nucleotide hydrolysis
is effectively utilized in channel opening;
b. What stage of the opening/closing cycle requires
energy;
c. By what (probable) mechanism the proposed scheme is
completed;
d. How, if at all, homeostasis is affected
The current hypothetical proposal is set out in three sec-
tions with appropriate illustrations.
Phase I: Activation
identifies the evidence that leads to the current proposal
and describes how the metabolic energy from nucleotide
triphosphate hydrolysis is utilised to assemble a func-
tional homo-oligomer of the E-NTPase/E-NTPDase, form-
ing a channel that is subsequently opened.
Phase II: Suggested: Ca2+/Mg2+Transport
Describes, with supporting evidence, how the energy
released from [NTP] o/ [NDP] o hydrolysis might be uti-
lized for opening the channel formed by the homo-oligo-
meric ENTPase/E-NTPDase.Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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Phase III: Termination of the transport processes
outlines the intracellular and extracellular factors that
would influence the termination of the Ca2+/Mg2+ trans-
port processes, and the experimental evidence obtained in
favor of the whole proposal.
Phase I: Activation of E-NTPase/E-NTPDase and channel 
formation
Membrane depolarization could locally alter protein con-
formation. This in turn could potentially induce post-
translational modification in the (intracellular) monomer
subunits of the E-NTPase/E-NTPDase, followed by trans-
location to the membrane (depending on the tissue
type(s) and functional requirement(s)) (Fig. 1). Fig. 2
shows the proposed functional state of the E-NTPase/E-
NTPDase after oligomerization and assembly in the mem-
brane to form a gated Ca2+/Mg2+ channel. Fig. 3, indicates
that the oligomerized E-NTPase/E-NTPDase is likely to
possess sensors to control the opening and closing of the
Ca2+/Mg2+ channel gate. Fig. 4, represents an interior view
of the E-NTPase/E-NTPDase in the functional state after
oligomerization and assembly in the membrane.
Probable energy sources and other significant factors are
as follows. The source of extracellular nucleotides could
be spontaneous release from dead cells or exocytosis from
live/damaged cells [20]. In ocular ciliary epithelial cells,
ATP is released in hypotonic conditions, and this release
Phase I: Activation Figure 1
Phase I: Activation. Based on direct experimental evidence, suppose that in response to electrical stimuli, an increased 
phosphatidylinositol turnover leads to elevated intracellular phospholipid. This in turn could induce post-translational modifica-
tion of the monomer subunits of E-NTPase/E-NTPDase in the intracellular milieu. Subsequently, the monomers are translo-
cated to the membrane, depending on the tissue type(s) and functional requirement(s).
Electrical Stimulation (see Fig 1;2;3-Mol.Cell.Biochem, 77;135-141(1987)
Increased Phosphatdylinositol 
turnover
Increased Phospholipid  turnover
E-NTPaseTranslocation 
to membrane
Increased Olgomerization  of E-NTPase monomer(s)
PHASE I: ACTIVATION
E-NTPase: ROLE AS A Ca2+/Mg2+ TRANSPORTER 
VIA CHANNEL GATING:Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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is inhibited by NPPB (5-nitro-2-(3-phenyl propylamine
benzoic acid), a potent inhibitor of CFTR (cystic fibrosis
transmembrane receptor) and p-glycoprotein mediated
ATP release [21]. On the other hand, the endogenous
CD39 of oocytes transforms under hypertonic conditions
to a conformation mediating ATP transport to the extra-
cellular environment, either by exocytosis or by acting as
an ion channel [22,23]. However, under what conditions
(hyper-or hypotonic) might CD39 assume an extracellu-
lar nucleotide hydrolyzing activity; and under those con-
ditions, can this property be coupled to ion influx? This
question remains unanswered.
At normal physiological temperature in presence of diva-
lent succinyl CoA, Con A mediates the oligomerization of
E-NTPase monomers/dimers to form a holoenzyme with
enhanced activity. Eosin iodoacetamide (EIAA), a fluores-
cein iodoacetamide that forms thioester bonds with
cysteine at neutral pH, enhances chicken gizzard ecto-
ATPase activity [24].
There are ten conserved cysteine residues in E-NTPase
(with additional cysteine residues in the N-terminal
region that are known to mediate disulfide bond forma-
tion, essential in oligomerization). CD39, an ecto-Ca2+/
Mg2+ apyrase that hydrolyses ATP and ADP [25], forms
tetramers and might act as a bivalent cation channel.
Phase I: Activation Figure 2
Phase I: Activation. Proposed model for E-NTPase/E-NTPDase in a functional state after oligomerization and assembly in 
the membrane, functioning as a gated channel.Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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However, the precise mechanism and functional proper-
ties are not known at present. CD39 expression is
associated with ATP release; it was speculated that ATP
release (along with drugs) into the extracellular milieu is
followed by the hydrolysis of the extracellular nucleotides
by CD39 [26].
Furthermore, native CD39 (ecto-ATP/Dase/ apyrase)
forms tetramers upon oligomerization. Loss of either of
the two transmembrane domains of rat CD39 ecto-ATP/
Dase impairs enzyme activity. It has been suggested that
the functional (holoenzyme) E-NTPase/E-NTPDase is a
homotrimer in mammals.
Differences in enzyme activity among different species
have been attributed to variations in the interaction
among the monomers resulting in homotrimeric holoen-
zyme formation (66 kDa-ATPase) [27]. It seems clear that
changes in the conformation of the E-NTPase/E-NTPDase
could mediate changes in the channel transport function.
Phase II: Ca2+/Mg2+ Transport
Fig. 5a, illustrates the possible utilization of the energy
released from [NTP] o /[NDP] o hydrolysis (-7.3 kcal mol-
1 or by formation of AMP, -10.9 kcal/mol-1) for opening
the channel formed by the homo-oligomeric E-NTPase/E-
NTPDase. This channel is postulated to open and close in
Phase I: Activation Figure 3
Phase I: Activation. The oligomerized E-NTPase/E-NTPDase would probably possess hypothetical sensors acting to open/
close the gates.
Sensor for opening 
of the channelTheoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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response to energy availability (Fig. 5b). Fig. 6A, is an art-
ist's impression of the three-dimensional configuration of
the E-NTPase/E-NTPDase in vivo. Ca2+ might enter the cell
and excess Mg2+ might leave by the influx and efflux
mechanisms depicted in Fig 6b.
The opening of the slow inward Ca2+ current channel in
cardiac sarcolemma during the plateau phase of the action
potential requires ATP [28]. Furthermore, protein kinase-
A (PKA) dependent phosphorylation appears to mediate
the increase in Ca2+ influx in hormonal modulation of
that process [29]. A similar model has been proposed for
sodium channels in nerve membranes, in which a cycle of
phosphorylation and dephosphorylation is proposed for
opening and closing [30].
Other corroborating evidence implicating E-NTPase in
Ca2+/Mg2+ transport via the gated channel is briefly sum-
marised. Rat cardiac sarcolemmal E-NTPase has consider-
able sequence homology with the human platelet
thrombospondin receptor CD36 [31]. An antibody
directed against the purified E-NTPase blocked the
increase in intracellular calcium concentration, implying
that the E-NTPase plays an unknown but significant role
in the delayed Ca2+ influx or Mg2+ efflux during the pla-
teau phase of the action potential (Unpublished observa-
tion). Activation of E-NTPase by millimolar
concentrations of Ca2+  and electrical stimulation is
linearly related to the contractile force developed in the
myocardium [32]. Gramicidin S inhibits the E-NTPase
activity and it attenuates the slow channel efflux in per-
fused frog left ventricles.
Phase I: Activation Figure 4
Phase I: Activation. Interior view of E-NTPase/E-NTPDase in a functional state in the membrane.Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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Based on these observations, we propose that E-NTPase
might be involved in providing energy for Ca2+/Mg2+
influx-efflux in the cardiac sarcolemma, opening the
channel formed by the E-NTPase/E-NTPDase protein by
altering the conformation of the sensors. The altered
channel sensor conformation opens the channel; loss of
the energy source allows the sensors to revert to the resting
state, which corresponds to channel closing.
There are at least two Mg2+ transport systems: (a) rapid
transport down the concentration gradient and (b) efflux
in low Ca2+ Ringer during ventricular perfusion in vitro. In
rat liver mitochondria, 50 nM cAMP or 250 µM ADP
induced rapid loss of 6 mmol of Mg2+/mg protein coupled
with the stimulation of ATP efflux. This effect was specific
and was blocked by adenosine nucleotide translocase
inhibitors. Evidently cAMP acts as a mobilizer of Mg2+ in
isolated rat liver mitochondria. Adenine nucleotide trans-
locase is the cAMP target [33].
Myocardial Mg2+ content is maintained at physiological
level by the sarcolemmal transport system, which pumps
Mg2+ across the plasma membrane when the extracellular
[Mg2+]o concentration is <1 mM and restores [Mg2+]i when
the heart is perfused with Ringer buffer containing 5 × 10-
7  M Mg2+. Failure of either of these two transport
Phase II: Ca2+/Mg2+ Transport Figure 5
Phase II: Ca2+/Mg2+ Transport. (A) Free energy released from ATP hydrolysis by E-NTPase on the outer membrane sur-
face would yield -7.3 kcal mol-1 or by formation of AMP by E-NTPDase would yield -10.9 kcal mol-1. (B) The energy is utilized 
for opening the channel formed by the E-NTPase/E-NTPDase, by altering the conformation of the sensors. This altered confor-
mation has an inherent channel-opening effect; loss of the energy source causes the sensors to revert to the resting state, 
which corresponds to channel closing.
Ca2+
Ca2+
Mg2+Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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mechanisms may result in a rise in [Mg2+]i, impairing the
contractile machinery of the myocardium [34].
Gramicidin S inhibits total Mg2+ efflux in the myocar-
dium, while epinephrine restores Mg2+ efflux and contrac-
tile force development in the frog ventricle perfused with
10 mM Mg2+. It should be pointed out that both E-NTPase
activity and myocardial contraction and relaxation are
inhibited by gramicidin S [35].
In the light of the evidence surveyed here, there would
appear to be a significant functional role for activated E-
NTPase in Ca2+ influx and Mg2+ efflux (or vice versa) in the
myocardium.
Phase III: Termination of the transport process
Fig. 7 summarizes the possible means by which the trans-
port process is terminated. There are several potential con-
tributing factors that can be grouped into two categories,
extracelluar and intracellular. Additional experimental
evidence is indicated. Based on the heterologous expres-
sion of ecto-apyrase in COS cells in the presence of tuni-
camycin, glycosylation might be required for homo-
oligomerization and nuclotidase activity. Conversely,
deglycosylation might impair the E-type nucleotidase
activity by weakening the monomer-monomer interac-
tion and altering the tertiary and quaternary structures,
result in the loss of holoenzyme. Essentially, glycosylation
and deglycosylation of the ecto apyrase (HB6) monomer
Phase II: Ca2+/Mg2+ Transport Figure 6
Phase II: Ca2+/Mg2+ Transport. (A) Three-dimensional impression of the E-NTPase/E-NTPDase in vivo. (B) It is possible 
that Ca2+ can enter the cell and excess Mg2+ can leave via the influx/efflux mechanisms depicted in the figure.
Ca2+
Mg2+ Ca2+
Mg2+Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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and the consequences for homodimer formation have
been regarded as an on-off switch for ecto nucleotidase
activity [36].
Fig. 8a is a three-dimensional impression of the ecto-
ATPase in vivo at the termination of ion transport. Fig. 8b
illustrates how biochemical modifications such as deglyc-
osylation of the E-NTPase/E-NTPDase oligomers might
cause dissociation of the homo-oligomers to individual
monomers This is a potential mechanism for the disas-
sembly of the functional channel and closure of Ca2+
influx and Mg2+ efflux. Also, an increase in membrane flu-
idity induced by cholesterol oxidation might cause defec-
tive association or disassociation due to weak interaction
among the E-NTPase monomers, whereas increased mem-
brane cholesterol might sustain higher E-NTPase activity.
Oligomerization of E-NTPase and associated increase of
activity could also be responsible for the rapid termina-
tion of the purinergic response mediated by extracellular
ATP [37].
The extracellular nucleotide mediated activation of chan-
nel gating could be terminated by ecto (extracellular)-ade-
nylate kinase, which catalyzes trans-phosphorylase
activity (ADP+ADP→ ATP+AMP). This enzyme has a
higher affinity for extracellular nucleotides than the
Phase III: Termination of the transport processes Figure 7
Phase III: Termination of the transport processes. (A) Several factors might contribute to the termination of Ca2+/Mg2+ 
transport via channel gating by E-NTPase/E-NTPDase: extracelluar and Intracellular. Additional experimental evidence is men-
tioned. Decreased flow of Ca2+/Mg2+ due to closing of the channel gate.
Potential  contributing  factors  for the termination of Ca2+/Mg2+  transporter  
function  via  channel  gating :
Extracelluar..,
i. Decreased extracelluar nucleotide(s) concentration
ii. Loss of free  energy availability on the extracellular surface
iii.Catalytically active ecto-kinase maintain the E-NTP level
Intracellular..,
i. Increased intracellular Ca2+/Mg2+ concentration
ii. Alteration in intracellular pH
iii. Deglycosylation of the E-NTPase holoenzyme 
iv. Increased activation of intracellular cholesterol oxidase 
Experimental Evidences..,
i. Verapamil mediated inhibition of E-NTPase activity and Ca2+/Mg2+ influx
ii.Attenuation of Ca2+influx by anti-rat cardiac sarcolemmal Ca2+/Mg2+ 
ectoATPase (IgG Fraction)Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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dephosphorylating enzyme (E-NTPase/E-NTPDase) or
ecto-nucleotide pyrophosphatase/phospho-diesterase
(ATP→ AMP +ppi) [38].
As the transport process winds down, ecto-adenylate
kinase mediated ATP generation might maintain the
extracellular nucleotide level. However, the precise bio-
chemical kinetic process by which this process is com-
pleted remains to be elucidated [39].
Pathophysiological Significance of E-type nucleotidase 
mediated Ca2+/Mg2+ transport
Impairment of E-Type nucleotidases during Ca2+ paradox
in isolated rat heart model warrants investigation of the
molecular mechanism(s) involved. Knowledge obtained
from these studies will elucidate the observed protective
effects of anti-rat cardiac Ca2+/Mg2+-ecto-ATPase antibod-
ies in ischemia reperfusion induced damage, which is a
corollary of organ transplantation. Furthermore, the anti-
proliferative effect(s) of these antibodies in left anterior
descending coronary artery smooth muscle cell(s) empha-
size the need to explore more fully the hypothesis pro-
posed in this article.
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Phase III: Termination of the transport processes Figure 8
Phase III: Termination of the transport processes. (A) Three-dimensional impression of the E-NTPase/E-NTPDase in 
vivo when termination of the ion transport function commences. (B) Biochemical modifications of the E-NTPase/E-NTPDase 
oligomers such as deglycosylation would probably cause instability, leading to dissociation of the homo-oligomers. Disassembly 
of the functional molecule would ensue, closing the Ca2+ influx and Mg2+ efflux processes, as portrayed in the figure.Theoretical Biology and Medical Modelling 2004, 1:3 http://www.tbiomed.com/content/1/1/3
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phatase; E-NTPDase = Ecto or Extracellular Nucleotide tri-
phosphate diphosphohydrolase; [Ca2+]i  = Intracellular
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